{
    "Trade/Device Name(s)": [
        "Applied Biosystems TaqPath COVID-19, Flu A, Flu B, RSV Select Panel",
        "Applied Biosystems TaqPath COVID\u201119, Flu A, Flu B, RSV Select Panel",
        "TaqPath COVID-19, Flu A, Flu B, RSV Select Panel",
        "TaqPath\u2122 COVID\u201119, Flu A, Flu B, RSV Select Panel"
    ],
    "Submitter Information": "Life Technologies Corporation (a legal entity of Thermo Fisher Scientific)",
    "510(k) Number": "K241806",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN200031"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF"
    ],
    "Summary Letter Date": "June 21, 2024",
    "Summary Letter Received Date": "June 21, 2024",
    "Submission Date": "June 21, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The Sars-Cov-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "SARS-CoV-2 (Orf1a, Orf1b, N genes)",
        "Influenza A virus (PB1, M genes)",
        "Influenza B virus (M, NS genes)",
        "Respiratory syncytial virus (NP, M, L protein genes)",
        "RNase P (internal human control)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Anterior nasal swab"
    ],
    "Specimen Container(s)": [
        "Viral Transport Medium (VTM)",
        "Universal Transport Medium (UTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems QuantStudio 5 Dx Real-Time PCR Instrument",
        "KingFisher Apex Dx Purification System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex real-time reverse transcription polymerase chain reaction (RT-PCR)",
        "Nucleic acid extraction"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex PCR",
        "Molecular detection",
        "Nucleic acid isolation and purification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Panel",
        "Kit",
        "Reagent",
        "Control",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Applied Biosystems TaqPath COVID-19, Flu A, Flu B, RSV Select Panel, a multiplex RT-PCR panel for detection and differentiation of SARS-CoV-2, influenza A/B, and RSV from respiratory swabs",
    "Indications for Use Summary": "Qualitative detection and differentiation of SARS-CoV-2, influenza A virus, influenza B virus, and RSV in nasopharyngeal and anterior nasal swab specimens from individuals with symptoms of respiratory infection, aiding differential diagnosis.",
    "fda_folder": "Microbiology"
}